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Abstract
Senescence is a robust cell cycle arrest controlled by the p53 and Rb pathways that acts as an important barrier to
tumorigenesis. Senescence is associated with profound alterations in gene expression, including stable suppression of E2f-
target genes by heterochromatin formation. Some of these changes in chromatin composition are orchestrated by Rb. In
complex with E2f, Rb recruits chromatin modifying enzymes to E2f target genes, leading to their transcriptional repression.
To identify novel chromatin remodeling enzymes that specifically function in the Rb pathway, we used a functional genetic
screening model for bypass of senescence in murine cells. We identified the H3K4-demethylase Jarid1b as novel component
of the Rb pathway in this screening model. We find that depletion of Jarid1b phenocopies knockdown of Rb1 and that
Jarid1b associates with E2f-target genes during cellular senescence. These results suggest a role for Jarid1b in Rb-mediated
repression of cell cycle genes during senescence.
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Introduction
Senescence is a robust cell cycle arrest that can be triggered by
various stress signals such as telomere attrition, oncogene
activation or DNA damage, which functions to protect cells
against malignant transformation [1],[2]. Senescent cells undergo
a series of events leading to marked morphological changes, the
expression of senescence-associated b-galactosidase (SA-b-gal) and
profound changes in gene expression, including activation of the
INK4A-ARF locus. The INK4A-ARF locus is a potent activator of
the p53 and RB tumor suppressor networks that enforce an
intricate program including the repression of E2F-target genes
required for proliferation [3,4]. Not surprisingly, the p53 and RB
proteins are commonly inactivated by viral oncoproteins such as
E1A or SV40LT thereby contributing to cellular transformation.
In human fibroblasts it has been found that senescence induction is
associated with dramatic changes in chromatin organization and
several chromatin modifying enzymes have been identified that
modulate the senescence response [5]. Both the INK4A–ARF locus
and genes controlled by RB and E2F are major targets of
epigenetic regulation during senescence. The INK4A-ARF locus is
repressed by concerted action of polycomb group proteins (PcG),
which impose trimethylation of histone H3 Lysine 27
(H3K27me3) and histone demethylases JARID1A (KDM5A)
and NDY1 (KDMB2B) that remove H3K4me3 and H3K36me3
from this locus respectively [6,7,8,9,10]. PcG-mediated repression
of the INK4A-ARF locus is counteracted by JMJD3 which actively
removes methylation on H3K27 [11,12]. In addition, the
promoter regions of E2F-target genes become enriched for
H3K9me3 and depleted for H3K4me3 during senescence, which
is important for gene silencing and correct execution of the
senescence response by the RB tumor suppressor network [13].
RB can be regarded as an adaptor protein that recruits several
histone modifiers to create a repressive complex to silence E2F-
target genes during senescence [5]. For example, RB has been
shown to recruit HDAC1, DNMT1, SUV39H1 and the SWI/
SNF complex to E2F-target gene promoters [5,14,15]. It has been
reported that inactivation of Suv39h1 prevents induction of
oncogene-induced senescence, which underscores H3K9 trimethy-
lation as a critical feature of senescence [16]. These observations
suggest a role for RB in heterochromatinization of E2F-target
genes in senescent cells. Concordantly, RB depletion prevents
heterochromatin formation in human diploid fibroblasts [13].
Recently, it has been found that RB has a specific and non-
redundant role during senescence in the repression of transcription
of E2F-target genes involved in DNA replication [17]. Moreover,
an RB mutant unable to associate with chromatin modifying
enzymes could not repress DNA replication during oncogene-
induced senescence [18]. However, this RB mutant was not
compromised in its ability to repress DNA replication during
quiescence or differentiation, underscoring the significant role of
chromatin modifying enzymes in repression of DNA replication
during senescence.
Based on the observations described above and the association
of Rb with several different chromatin remodeling enzymes, we
argued that Rb may recruit additional chromatin remodeling
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e25235enzymes that contribute to the suppression of E2f-target genes.
The identification of such enzymes is potentially compromised by
the notion that inactivation of the RB pathway only is not
sufficient to bypass senescence in both murine and human cells
[1]. Using a functional genetic screen in murine models in which
abrogation of the Rb pathway is sufficient to bypass senescence we
discovered that the histone demethylase Jarid1b (Kdm5b) is a
critical component of the Rb-E2f pathway. In addition, we found
that Jarid1b (Kdm5b) associates with E2f-target genes during
senescence, suggesting it may contribute to the repression of E2f-
target genes during senescence.
Results
A screen for bypass of senescence in MN-tsLT cells
identifies Jarid1b
To identify novel chromatin remodeling enzymes that specif-
ically cooperate with Rb in tumor suppression, we used a
senescence model in which abrogation of the Rb pathway is
sufficient to bypass senescence (Figure 1A). The primary mouse
striatum cell line MN-tsLT has been conditionally immortalized
through the expression of a temperature-sensitive mutant (tsA58)
of SV40 large-T antigen (tsLT) [19]. At the permissive
temperature MN-tsLT cells proliferate rapidly but they enter into
a synchronous senescence-like arrest when shifted to the non-
permissive temperature (39uC). MN-tsLT cells arrested at 39uC
display several hallmarks of cellular senescence including SA-b-gal
positivity, senescent morphology, decreased expression of E2f-
target genes and activation of the p53 target gene and cell cycle
inhibitor Cdkn1a (p21
cip1) (Figure 2C and D, Supplementary
Figure S1B–E). However, similar to murine embryonic fibroblasts
(MEFs) and in contrast to human cells [13], senescence-associated
heterochromatin foci (SAHF) cannot be detected in MN-tsLT
cells. It has been shown previously that inhibition of the p19
ARF-
p53 pathway is sufficient to bypass senescence in this model
[20,21,22](Figure 1A). We tested whether loss of Rb1 expression in
MN-tsLT cells was sufficient to bypass senescence. As can be
seen in Figure 1, the expression of an shRNA targeting Rb1
(Supplementary Figure S1A) results in the rescue of the senescence
phenotype analogous to inactivation of the Ink4a-Arf locus or
knockdown of p53. As such, the dependency on either p53 or Rb
in MN-tsLT cells offers an opportunity to find novel components
of the p16
INK4A-Rb pathway.
For this purpose we constructed a retroviral shRNA library
consisting of multiple independent shRNAs directed against 50
known and putative chromatin binding and modifying enzymes:
Figure 1. A functional shRNA screen in conditionally immortalized cells. (A) Colony formation assay at 39uC of MN-tsLT cells transduced
with pRS-GFP, pRS-Ink4a (targeting both Ink4a and Arf), pRS-p53 and pRS-Rb (B) Schematic outline of the senescence bypass screen using MN-tsLT
cells. Cells were transduced at the permissive temperature (32uC) with 50 pools of retroviral knockdown vectors targeting candidate chromatin
binding and modifying enzymes. Each pool contains 4 unique shRNAs targeting a single transcript. The transduced cells were seeded at the non-
permissive temperature (39uC) for a colony formation assay. After 2 weeks cells were fixed and stained with crystal violet. (C) Quantification of the
colony formation assay of the shRNA screen in MN-tsLT cells shown are the average absorption and 26standard deviations (SD) from the median of
the samples.
doi:10.1371/journal.pone.0025235.g001
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demethylase 1 (LSD1)-like family members, methyl CpG binding
proteins and DNA methylases [23,24]. The shRNAs were pooled
in 50 sets of 4 vectors, in which each set of vectors was designed to
target a single transcript (Supplementary Table S1).
MN-tsLT cells were transduced at 32uC with the 50 individual
sets of shRNAs in a single-well format and seeded for long term
clonogenic outgrowth assays (Figure 1B). As a positive control we
used a functional shRNA targeting p53 that was used in previous
studies [21,22]. We used an shRNA targeting green fluorescent
protein (GFP) as a negative control throughout this study. As
expected, knockdown of p53 prevented senescence induction of
MN-tsLT cells (Figure 1A and 1C). Clonogenic outgrowth was
quantified by measuring crystal violet absorption. Only wells with
an absorption value greater than the median plus 26 standard
deviation were considered as hits (Figure 1C). Except for the
positive control, only the shRNA pool targeting Jarid1b (Kdm5b,
Plu-1, Rbp2-h1) [25,26] fitted these criteria. Jarid1b is a member of
the Jarid1 family of H3K4 demethylases [27,28,29,30,31]. This
family encompasses four members (Jarid1a-d) with a high degree
of homology [32], all capable of demethylating tri- and di-
methylated H3K4 and function as transcriptional repressors.
Although shRNA pools against Jarid1 family members a, c and d
were present in the library they did not score as hits. On one hand,
this could be due to inefficient knock-down of their respective
targets but, in contrast to Jarid1b, we did not detect expression of
Jarid1a, c or d in MN-tsLT cells (data not shown).
To rule out off target effects [33], each of the individual
knockdown vectors of the Jarid1b shRNA pool were introduced
into MN-tsLT cells and tested for their ability to bypass senescence
and their efficiency of knocking down Jarid1b. We found two
independent shRNAs targeting Jarid1b (pRS-Jarid1b#1 and #3)
that allowed bypass of senescence in MN-tsLT cells. Both shRNAs
reduced Jarid1b mRNA levels, confirming Jarid1b as an on-target
hit (Figures 2A and B). In addition, we found that Jarid1b mRNA
expression is highly induced when MN-tsLT cells are shifted to the
non-permissive temperature, suggesting a role for Jarid1b in the
execution of senescence (Figure 2B). Importantly, the expression of
Jarid1b is not a surrogate marker for the absence of cellular
proliferation as MN-tsLT cells that express knockdown vectors
against p53, and cycling at 39uC, retain high levels of Jarid1b.
Next, we analyzed MN-tsLT cells transduced with the two
functional Jarid1b-knockdown vectors for typical senescence
markers [1]. Whereas the negative control vector transduced cells
stained highly positive for b-galactosidase, cells expressing the
functional Jarid1b-knockdown vectors did not or stained weak for
b-galactosidase (Figures 2C and 2D). Moreover, Jarid1b-knock-
down cells did not show a typical senescent morphology observed
in the control vector-transduced cells (Supplementary Figure S1B).
Expression of two bona fide cell cycle markers Ccna1 and Pcna was
restored in Jarid1b knockdown cells (Supplementary Figure S1C
and S1D). Remarkably, levels of Cdkn1a, a marker of slowly cycling
and senescent cells, remained high in proliferating Jarid1b-
knockdown cells (Supplementary Figure S1E). Taken together,
Figure 2. Multiple Jarid1b-targeting shRNAs prevent senes-
cence induction of MN-tsLT cells. (A) Colony formation assay of
MN-tsLT transduced with two independent Jarid1b shRNAs derived
from the pool (#1 and #3). pRS-GFP was used as a negative control,
pRS-p53 was used as a positive control. (B) Relative Jarid1b mRNA
expression levels determined by RT-qPCR. Samples are derived from
cells shown in (A) and mRNA values were normalized to Gapdh and
proliferating cells at 32uC. (C) b-galactosidase assay of MN-tsLT cells
from (A). (D) Quantification of b-galactosidase positive cells from (C).
doi:10.1371/journal.pone.0025235.g002
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down do not undergo senescence when shifted to the restrictive
temperature.
Jarid1b functions in the Rb pathway
Suppression of either the p16
INK4A-Rb or the p19
ARF-p53-
p21
cip1 pathways can mediate bypass of senescence in MN-tsLT
cells (Figure 1A). To determine in which of these two pathways
Jarid1b operates, we examined gene expression profiles of
senescent MN-tsLT cells and MN-tsLT cells with knockdown of
p53, Rb1, Ink4a (Ink4a-Arf locus) or the Jarid1b shRNA pool.
Unsupervised hierarchical clustering of mRNA expression profil-
ing revealed that the transcriptional profiles of Jarid1b-knockdown
and Rb-knockdown cells were highly similar (Figure 3A), suggest-
ing that Rb and Jarid1b may operate in the same pathway.
Concordantly, expression of established E2f-target genes was
downregulated in senescent cells but restored in Rb1 and Jarid1b-
knockdown cells similar to p53-knockdown cells (Figure 3B). To
ask whether Jarid1b also functions in the p53 pathway we looked
for the expression of bona fide p53-target genes in our micro-array
data sets. As expected, p53-target genes were upregulated in
senescent cells and downregulated in p53-knockdown cells
(Figure 3C). In contrast, p53-target genes were induced in both
Rb1-knockdown and Jarid1b-knockdown cells to a similar extent as
in senescent MN-tsLT cells. These data may indicate that Jarid1b
does not function in the p19
ARF-p53-p21
cip1 pathway. Moreover,
Jarid1b is not a transcriptional target of p53 as knockdown of p53
does not affect the expression of Jarid1b in MN-tsLT cells
(Figure 2B).
Interestingly, it was previously reported that the protein product
of a JARID1B splice variant binds to RB in co-immunoprecipi-
tation experiments in MCF7 human breast cancer cells [34].
However, the functional significance of JARID1B in RB-mediated
suppression of E2F-target genes was not explored. This is not a
trivial question as over 150 proteins are known to interact with RB
(www.hprd.org) but many of those do not modulate E2F-target
gene expression. To further substantiate the interaction between
Jarid1b and Rb, we performed a co-immunoprecipitation
experiment in senescent MN-tsLT cells using an antibody against
Jarid1b. Indeed we were able to detect endogenous Rb in the
Jarid1b immunoprecipitation by western blotting using an Rb
antibody, demonstrating that Jarid1b physically interacts with Rb
in senescent MN-tsLT cells (Figure 3D). The expression data
together with the interaction of Jarid1b and Rb may suggest that
Jarid1b is involved in Rb-, but not p53, mediated execution of
senescence in MN-tsLT cells.
Jarid1b knockdown phenocopies loss of Rb in
Rb-dependent senescence models
To confirm that Jarid1b functions in the Rb pathway we tested
whether loss of Jarid1b could bypass senescence in another
senescence model in which abrogation of the Rb pathway is
sufficient for bypass. Primary MEFs with knockdown of p53 are
unable to undergo senescence whereas knockdown of Rb1 does not
result in bypass of senescence. Transduction of primary MEFs
with the Jarid1b shRNA pool did not result in bypass of senescence
(Supplementary Figure S2A). It has been shown previously that
MEFs deficient for all three pocket proteins Rb1, Rbl1 and Rbl2 are
unable to undergo senescence [35,36]. In contrast, MEFs only
deficient for Rbl1 and Rbl2 retain the ability to undergo senescence
[37], suggesting that in these double knockout MEFs (DKO
MEFs) Rb is the only retinoblastoma gene family member that
executes the senescence program. We subsequently tested whether
our knockdown vectors against Jarid1b could replace knockdown
of Rb1 to override cellular senescence in these DKO MEFs.
Indeed, depletion of Jarid1b or Rb1 prevented cellular senescence
in DKO MEFs (Figure 4A). Unlike senescent DKO MEFs, Rb1
and Jarid1b-knockdown cells did not stain positive for b-
galactosidase (Figure 4B and Supplementary Figure S2B) and
did not show a senescent morphology (Supplementary Figure
S2C). Mutations in Ink4a, Arf and p53 can lead to spontaneous
immortalization of MEFs [1]. To exclude that Jarid1b-knockdown
DKO MEFs were spontaneously immortalized (SPi), we assessed
the status of the p53 pathway by treating cells with the DNA-
damaging agent cisplatin and subsequently analyzed the expres-
sion of the p53 target gene Cdkn1a (Figure 4C). In contrast to SPi
colonies derived from pRS-GFP transduced DKO MEFs, Cdkn1a
expression was potently induced in Jarid1b-knockdown DKO
MEFs after treatment with cisplatin. Collectively, these results
show that Jarid1b-knockdown can phenocopy Rb1-knockdown in
the bypass of cellular senescence in both MN-tsLT cells and DKO
MEFs.
Jarid1b associates with E2f-target genes during
senescence
Using chromatin immunoprecipitation (ChIP) with an RB
antibody followed by deep sequencing it was shown that RB
associates with E2F-target genes involved in DNA replication and
cell cycle progression in senescent diploid human fibroblasts [17].
RB orchestrates the senescence response by recruiting chromatin
modifying enzymes to induce and maintain a repressive state of
heterochromatin surrounding E2F-target genes [38,39]. JARID1B
has been shown to function as a transcriptional repressor by
demethylating the active transcription mark H3K4me3 [40,41].
We hypothesized that Jarid1b associates with Rb during
senescence to remove the activating H3K4-trimethyl mark at
promoters of E2f-target genes. To test whether Jarid1b associates
with E2f-target genes during senescence we determined Jarid1b
occupancy at E2f binding sites of E2f-target gene promoters in
cycling and senescent MEFs by performing a ChIP experiment
with an antibody specific for Jarid1b. We confirmed that MEFs at
passage 8 (P8) were senescent as they displayed hallmarks of
senescence that were not observed in passage 5 (P5) MEFs, such as
positive staining for b-galactosidase, induction of senescence-
associated tumor suppressor genes Ink4a, Arf and Cdkn1a, and
downregulation of E2f-target genes Ccne1, Mcm3, Pcna and Rbl1
(Figures 5A and B). In support of our hypothesis, we found an
increased association of Jarid1b with promoters of E2f-target genes
but not at promoters of control genes in senescent MEFs
(Figure 5C). Next, we tested whether Jarid1b occupancy at E2f-
target gene promoters was correlated with decreased H3K4
methylation at these promoters, by performing a ChIP with an
antibody specific for H3K4me3 in the same chromatin factions.
Indeed, we found that H3K4me3 was severely depleted at
promoters of E2f-target genes in senescent cells (Figure 5D).
Similar to MEFs, we observed an enhanced occupancy of Jarid1b
at E2f-target gene promoters in senescent MN-tsLT cells
associated with depletion of H3K4me3 levels (Supplementary
Figure S3A and S3B). Taken together, these results demonstrate
that there is increased binding of Jarid1b to E2f-target genes
during senescence, which is correlated with a strong reduction of
H3K4me3 of these E2f-target genes.
Discussion
Chromatin is extensively modified during senescence to allow
selective repression of E2F-target genes that control cellular
Jarid1b Controls E2f-Target Genes
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heterochromatin formation that are enriched for H3K9 methyl-
ation but depleted in H3K4 methylation [3,13]. H3K4me3 is
exclusively associated with the 59 regions of practically all active
genes whereas H3K9me3 is invariably enriched in transcription-
ally silent regions [42,43]. Several studies suggest that the
formation of an epigenetic landscape that induces silencing of
E2F-target genes during senescence is orchestrated by RB. In
contrast to proteins responsible for H3K9 methylation of E2F-
target genes, it is unknown which enzymes selectively demethylate
H3K4me3 of E2F-target genes. Our data suggest that Jarid1b
functions in a repressive complex with Rb to remove the H3K4
activation mark from E2f-target genes, a process that could
contribute to their stable silencing during senescence in murine
cells.
Recently, Lowe and colleagues, identified a non-redundant role
for RB, but not p107 and p130, in promoting senescence by
specifically repressing E2F-target genes involved in DNA replica-
tion [17], providing a rationale for why RB, but not its family
members p107 and p130, is disabled in many, if not all, tumor
cells [44]. Although near complete loss of RB may delay
senescence induction [17], inactivation of Rb is not sufficient to
bypass senescence in almost all models of senescence [4,45]. We
find here that suppression of Jarid1b can substitute for Rb1 loss in
override of senescence in mouse fibroblasts that can be bypassed
by knockdown of Rb1 alone, indicating a role for Jarid1b in the Rb
pathway.
JARID1B has been implicated as an oncogene in breast and
prostate cancer but as a tumor suppressor in melanoma, which
may be attributed to tissue-specific regulation of genes that control
carcinogenesis by JARID1B. For example, JARID1B was reported
to transcriptionally regulate BRCA1 in breast cancer, via direct
interaction with promoter sites [40,41,46]. JARID1B is highly
expressed in benign human melanocytic nevi, which invariably
harbor oncogenic mutations but are protected from progressing
into malignant tumors by oncogene-induced senescence [47,48].
Importantly, it was found that the RB tumor suppressor network
and not the p14
ARF-p53-p21
cip1 axis has a key role in the
induction of senescence in naevi [48]. This study provided a
rationale for the frequent genetic alterations in the p16
INK4A-RB
pathway in melanoma and the genetic predisposition of patients
with germline mutations of the p16
INK4A-RB tumor suppressor
network to melanoma [49]. It was reported that RB recruits
HDAC1, HP1b and SUV39H1 to induce senescence in naevi
[39]. We speculate that JARID1B assists RB in senescent naevi to
aid in the execution of senescence. Indeed, JARID1B is
downregulated in malignant melanoma that progressed from a
senescent naevus, while restoration of JARID1B expression in
malignant melanoma inhibits proliferation [50]. It was recently
found that in contrast to the bulk of melanoma tumor cells
expressing very low levels of JARID1B, a small slow-growing
subpopulation expresses high levels of JARID1B. The JARID1B
expressing subpopulation was found to act as tumor-initiating cells,
giving rise to highly proliferative progeny with low JARID1B
expression [47]. We speculate that the high proliferation rate of
melanoma cells with low JARID1B expression may be caused by
depression of E2F-target genes and the consequential activation of
the cell cycle.
In conclusion, we identified a novel component of the Rb-
repressor complex that associates with E2f-target genes during
senescence correlating with a strong decrease of H3K4me3 at the
same promoters. Jarid1b binds to Rb in senescent cells and
Jarid1b-knockdown can substitute for Rb1-knockdown in senes-
cence models that are solely dependent on functional Rb. We
speculate that one of the functions of Jarid1b is to repress E2f-
target genes, providing a possible explanation for the differential
expression of JARID1B in distinct tumors although additional
research is needed to dissect the functional role of the plasticity in
JARID1B expression in different tumor types.
Materials and Methods
shRNA Library Design
Design of oligonucleotides was done as previously described
[51]. Multiple independent oligonucleotides (4 oligos/transcript)
were designed to target the Jumonji C (JmjC)-domain-containing
proteins, the lysine specific demethylase 1 (LSD1)-like family
members, methyl CpG binding proteins and DNA methylases (see
Supplemental table S1 for sequences). The oligonucleotides were
pooled in 50 sets of 4 vectors, where each set of vectors was
designed to target a single transcript, and cloned into the pRISC
retroviral vector as previously described [51,52]. More informa-
tion and protocols on the oligo design and vector can be found at:
http://www.screeninc.nl. (see Supplementary Table S1 for
sequences).
Cell Lines and Cell Culture
All cell lines were cultured in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal calf serum and antibiotics.
MN-tsLT mouse striatum cells express a mutant version of the
huntingtin protein with an expanded polyglutamine repeat from a
knock-in MN-tsLT allele and a stably introduced temperature
sensitive mutant (tsA58) of SV40T antigen [19]. Primary MEFs
deficient for the pocket proteins encoding genes Rbl1 and Rbl2
(DKO MEFs) were obtained from Dannenberg [37].
Viral Transduction
Retroviral supernatants for each shRNA-pool were produced by
transfection of phoenix packaging cells using the calcium-
phosphate precipitation method. Forty-eight hours post-transfec-
tion, supernatants were harvested, filtered through a 0.45-mm filter
and used for infection of target cells.
shRNA library Screen, Colony Formation and Proliferation
Assays
MN-tsLT cells grown at the permissive temperature (32uC) were
seeded at a density of 2610
5 cells per well of a 6-well dish and used
for viral infection the next day. After infection cells were selected
with puromycin (1 mg/ml) for 2 days. The puromycin selected
MN-tsLT cells were seeded at a density of 1610
4 cells per well of a
6-well dish and 6 hrs after plating shifted to the non-permissive
temperature 39uC. After 2 weeks, cells were fixed with 4%
formaldehyde, stained with 0.1% crystal violet and photographed.
Crystal violet was extracted using 10% acetic acid and quantified
at OD 590 nm.
Figure 3. Jarid1b operates in the Rb pathway. (A) Unsupervised hierarchical clustering of mRNA expression of MN-tsLT cells stably transduced
with the indicated knockdown vectors grown under the permissive or non-permissive temperature. (B) Relative expression of E2f-target genes from
expression profiles from (A). (C) Relative expression of p53 target genes from expression profiles from (A). Values were normalized to MN-tsLT cells
cycling at 32uC. (D) Co-immunoprecipitation of Rb and Jarid1b. Protein fractions were isolated from MN-tsLT cells cultured for 4 days at 39uC followed
by immunoprecipitation of Jarid1b. Immunoprecipitated samples were analyzed by western blot and probed with anti-Rb antibody.
doi:10.1371/journal.pone.0025235.g003
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with retroviral shRNA constructs at passage 3, selected for two
passages and subsequently seeded at a density of 1610
4 per 10 cm
Ø dish for a colony formation assay. Cells were fixed and stained
after 3 weeks. Growth curves were performed according to the
3T4 protocol and counted every 4 days. DKO MEFs (passage 2)
were transduced with retroviral shRNA constructs at passage 3
and selected for two more passages with puromycin (1 mg/ml).
Figure 4. Jarid1b-knockdown is able to bypass cellular senescence in MEFs deficient for Rbl1 and Rbl2. (A) MEFs, deficient for Rbl1 and
Rbl2 (DKO MEFs), were transduced with functional Jarid1b or Rb1 retroviral knockdown vectors and seeded for a colony formation assay. pRS-GFP was
used as a negative control. (B) b-galactosidase quantification of DKO MEFs from (S2B). (C) Western blot analysis of p21
cip1 in DKO MEFs from (A)
treated with cisplatin o/n. pRS-GFP sample in first two lanes are early passage (e.p.) DKO MEFs. Spontaneously expanded colony outgrowths of pRS-
GFP (SPi: spontaneously immortalized) transduced DKO MEFs from (A) were used as a control. Cdk4 staining serves as a loading control.
doi:10.1371/journal.pone.0025235.g004
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PLoS ONE | www.plosone.org 8 September 2011 | Volume 6 | Issue 9 | e25235Passage 5 DKO MEFs were seeded 1610
4 cells per well of a 6-well
plate for a colony formation assay. Cells were fixed and stained
after 2 weeks.
Chromatin Immunoprecipitation
ChIP assays were performed using a commercially available
ChIP assay kit (Simple ChIP Cell Signaling Technology, #9002)
following the manufacturer’s instructions. In short, MEFs and
MN-tsLT cells were cultured in 15 cm Ø dishes and fixed with 1%
formaldehyde (Sigma-Aldrich) for 10 min, followed by 2 washes
with ice-cold PBS containing 1 mM PMSF. For each sample
4610
7 isolated nuclei were resuspended in 1 ml buffer B and
treated with 6 ml micrococcal nuclease (2000 gel units/ml) for
20 min at 37uC, followed by sonication with a Branson Sonifier
250 for 3 times 10 s with 30 s-off interval times at output setting 2
for MEFs, and 5 times 15 s with 30 s-off interval times at output
setting 2 for MN-tsLT cells. DNA was recovered from immune
complexes on protein A-agarose beads with the following
antibodies: Jarid1b (#3273, Cell Signaling Technology),
H3K4me3 (ab1012, Abcam), H3 (#4620, Cell Signaling Tech-
nology) and normal rabbit IgG (#2729, Cell Signaling Technol-
ogy). Real-time qPCR was performed using FastStart Universal
SYBR Green Master (Roche) in a 7500 Fast Real-Time PCR
System (Applied Biosystems). ChIP primers used are derived from
Blais [53], Rowland [54] and Barradas [12] and listed in
Supplementary Table S1. Data are presented as percentage of
bound minus IgG controls divided by input and normalized to the
proliferating condition (P5 for MEFs and 32uC for MN-tsLT cells)
of 3 independent ChIPs on a single chromatin fraction. For MN-
tsLT cells, the experiments were performed in 3 biological
triplicates and for the MEFs in biological duplicates.
Protein Extraction, Co-Immunoprecipitation and Western
Blotting
Cells were lysed on ice with RIPA (150 mM NaCl, 50 mM Tris
pH 8.0, 1% NP40, 0.5% sodium deoxycholate (DOC), 0.1%
Sodium Dodecyl Sulfate (SDS)). Total protein (20–40 mg) was used
for Western analysis with antibodies for p21 (F-5, Santa Cruz
Biotechnology) and CDK4 (C-220, Santa Cruz Biotechnology).
Co-immunoprecipitation was performed using total cell lysate of
8610
6 senescent MN-tsLT cells after culture for 4 days at 39uC.
Binding of Jarid1b to Rb, was analyzed by immunoprecipitation
with 8 ml Jarid1b (#3273, Cell Signaling Technology) in ELB
(250 mM NaCl, 50 mM Hepes pH 7.3, 0.1% NP40 and
Complete protease inhibitor cocktail from Roche) and subsequent
Western analysis with an antibody against Rb (#554136, BD
Pharmingen).
Quantitative RT-qPCR
RNA was extracted using TriZOL (Invitrogen) according to the
manufacture’s protocol. cDNA synthesis and subsequent quanti-
tative RT-PCR assays were performed to measure mRNA levels of
genes using the 7500 Fast Real-Time PCR System as previously
described [52]. Relative mRNA levels of each gene shown were
normalized to the expression of Rpl4, Gapdh, Actin or Rpl13 as
indicated. The sequences for the primers for assays using SYBR
Green master mix are listed in Supplementary Table S1.
b-Galactosidase Staining
Cells were washed with PBS and fixed with 0.5% gluteralde-
hyde (in PBS) for 159 at RT. Fixed cells were washed with PBS
supplemented with 1 mM MgCL2. Cells were subsequently
incubated 4–6 hrs (for MN-tsLT cells) or 10–12 hrs (for MEFs)
at 37uC in staining solution (PBS pH 6.0, 5 mM K4Fe(CN)
6
*3H2O, 5 mM K3Fe(CN)
6, 1 mM MgCl2, 1 mg/ml X-Gal). All
cells were processed simultaneously to allow comparison. A total of
1000 cells were counted per plate and scored for SA-b -Gal
positive cells. For all SA-b -Gal stainings, the representative of at
least two independent experiments is shown.
Unsupervised Hierarchical Clustering
MN-tsLTcells were transduced with the indicated shRNAs,
puromycin selected and shifted to the non-permissive temperature
as indicated. RNA samples were made in TriZOL (Invitrogen)
according to the manufacturer’s instructions, RNA was cleaned
with the RNeasy mini kit (#74106, Qiagen) and DNase treated
with the RNase-free DNase Set (#79254, Qiagen) according to
the manufacturer’s protocols. RNA was amplified using the
Illumina TotalPrep RNA amplification Kit (Part Number AMIL
1791) and subsequently hybridized to an Illumina HumanWG-6
V3 beadchip (BD-101-0603). Unsupervised hierarchical clustering
analysis was performed after background subtraction and
normalization with BeadStudio analysis software from Illumina.
Supporting Information
Figure S1 Jarid1b-knockdown prevents senescence in MN-tsLT
cells without affecting the induction of CDKNA1 expression. (A)
Protein expression of Rb in senescent MN-tsLT cells transduced
with a control vector (pRS-GFP)o ra nRb1-knockdown vector
(pRS-Rb). l.c.: loading control. (B) Brightfield images of MN-tsLT
cells transduced with the indicated knockdown vectors and
cultured at 39uC. pRS-GFP was used as a negative control.
pRS-p53, and pRS-Rb were used as positive controls. The shRNA
pool targetting Jarid1b and the two most potent Jarid1b knockdown
vectors (#1 and #3) were tested. Cells transduced with negative
control vectors show a typical round and flat morphology,
characteristic of senescent cells. (C, D and E) RT-qPCR analysis
shows relative mRNA expression of Ccna1 (cyclin A) (C), PcnA (D)
and Cdkn1a (E) as described in figure 2B.
(TIF)
Figure S2 Jarid1b-knockdown can replace Rb1-knockdown to
prevent cellular senescence in Rb1
wt, Rbl1
2/2, Rbl2
2/2 (DKO)
MEFs. (A) Colony formation assay of primary MEFs transduced
with the indicated knockdown vectors. Late passage infected
MEFs were seeded at low density in a 10 cm dish allowed for
colony formation for 2 weeks and colonies were visualized by
crystal violet. (B) b–galactosidase staining of DKO MEFs from
Figure 5. Jarid1b associates with the promoters of E2f-target genes during senescence. (A) Analysis of cycling, passage 5 (P5) and
senescent, passage 8 (P8), primary MEFs for hallmarks of senescence. Shown are a proliferation curve of MEFs according to the 3T4 protocol (left
panel, results shown as means 6 SD), b–galactosidase staining of P5 and P8 MEFs (center panel) and quantification of b–galactosidase positive cells
(right panel). (B) Analysis of mRNA expression of the indicated genes from P5 and P8 MEFs. Values are normalized to P5 and shown as means 6 SD.
(C) Jarid1b ChIP in P5 MEFs and P8 MEFs. The degree of enrichment at indicated promoters of E2f-target genes and control genes was measured by
qPCR, non-specific binding of rabbit IgG controls was subtracted and results are presented as percentage of bound/input normalized to P5 samples
for each gene. (D) H3K4me3 ChIP in P5 MEFs and P8 MEFs, performed as in (C). Non-specific binding of rabbit IgG controls was subtracted and
quantification of H3K4me3 samples was normalized to H3-immunoprecipitations in the same experiment. PD: passage doubling, P: passage.
doi:10.1371/journal.pone.0025235.g005
Jarid1b Controls E2f-Target Genes
PLoS ONE | www.plosone.org 9 September 2011 | Volume 6 | Issue 9 | e25235Figure 4A. (C) Brightfield images of DKO MEFs transduced with
the indicated constructs. As a negative control pRS-GFP was used.
The negative control shows a round and flat morphology, which is
typical of senescent cells.
(TIF)
Figure S3 Jarid1b associates with the promoters of E2f-target
genes during senescence. (a) Jarid1b ChIP in MN-tsLT cells when
cycling (32uC) or in senescence (39uC). The degree of enrichment
at indicated promoters of E2f-target genes and control genes was
measured by qPCR, non-specific binding of rabbit IgG controls
was subtracted and results are presented as percentage of bound/
input normalized to 32uC samples. (b) H3K4me3 ChIP in MN-
tsLT cells when cycling (32uC) or in senescence (39uC), performed
as in (a). Non-specific binding of rabbit IgG controls was
subtracted and quantification of H3K4me3 samples was normal-
ized to H3-immunoprecipitations performed in the same exper-
iment on the same samples.
(TIF)
Table S1 Chromatin modifiers knockdown library. Sequences of
knockdown vectors and sequences of primers are depicted.
(XLS)
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